ITGR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Integer Holdings Corp (ITGR) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown strong financial performance in the latest quarter and has positive long-term growth potential, the current technical indicators are bearish, and there are no immediate positive trading signals or catalysts to suggest a strong entry point. Holding or waiting for a better entry point is recommended.
The technical indicators are bearish. The MACD histogram is negative and expanding, the RSI is neutral at 38.378, and the moving averages indicate a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading below the pivot level of 85.746, with support at 82.687 and resistance at 88.806.
Strong Q4 2025 financial performance with revenue up 5.02% YoY and net income up 48.63% YoY.
Positive analyst upgrades, including a raised price target from Raymond James to $101 and Benchmark upgrading the stock to Buy.
Potential for long-term growth as headwinds ease by late 2026 and new products contribute to revenue growth.
Current technical indicators are bearish, suggesting potential near-term downside.
No immediate Intellectia Proprietary Trading Signals (AI Stock Picker or SwingMax) to support a buy decision.
Neutral trading sentiment from hedge funds and insiders with no significant trends.
Headwinds from underperforming products expected to impact growth through 2026.
In Q4 2025, Integer Holdings reported strong financial results: revenue increased by 5.02% YoY to $472.06M, net income rose by 48.63% YoY to $48.61M, EPS grew by 53.33% YoY to $1.38, and gross margin improved to 27.11%, up 3.83% YoY.
Analysts are generally positive on the stock, with recent upgrades and raised price targets. Raymond James raised the price target to $101 and maintained an Outperform rating, citing long-term growth potential. Benchmark upgraded the stock to Buy with a $95 price target following strong Q4 results. However, Citi maintained a Neutral rating with a price target of $92, reflecting some caution.
